Suppr超能文献

药物性肝炎患者中药物与肝脏成分联合诱导的白细胞迁移抑制。

Leukocyte migration inhibition induced by the combination of drug and a liver constituent in patients with drug-induced hepatitis.

作者信息

Morizane T

出版信息

Gastroenterol Jpn. 1978;13(4):281-9. doi: 10.1007/BF02774051.

Abstract

The leukocyte migration inhibition test in agarose medium was performed in 23 cases of clinically diagnosed drug-induced hepatitis. When the test antigen was the combination of soluble phase of a liver homogenate fractionated by Sephadex G-100 which should have contained liver specific antigen and the offending drug the leukocyte migration was inhibited in 86% of cases. Whereas none of 12 cases of drug allergy without hepatic injury showed a positive result with the same combination of antigens. Other organ homogenate-muscle and kidney-never gave positive results when mixed with the offending drugs in cases of drug-induced hepatitis. It was concluded that in hypersensitivity type drug-induced hepatitis cell-mediated immunity might be established to the complex of liver specific antigen and the drug.

摘要

对23例临床诊断为药物性肝炎的患者进行了琼脂糖培养基中的白细胞迁移抑制试验。当试验抗原为经葡聚糖凝胶G - 100分级分离的肝匀浆可溶相(其中应含有肝脏特异性抗原)与致病药物的组合时,86%的病例白细胞迁移受到抑制。而12例无肝损伤的药物过敏患者,使用相同抗原组合均未显示阳性结果。在药物性肝炎病例中,当其他器官匀浆(肌肉和肾脏)与致病药物混合时,从未得到阳性结果。得出的结论是,在超敏型药物性肝炎中,可能针对肝脏特异性抗原与药物的复合物建立了细胞介导的免疫反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验